Form 8-K - Current report:
SEC Accession No. 0001102624-14-000412
Filing Date
2014-03-20
Accepted
2014-03-20 08:01:39
Documents
2
Period of Report
2014-03-19
Items
Item 5.05: Amendments to the Registrant's Code of Ethics, or Waiver of a Provision of the Code of Ethics

Document Format Files

Seq Description Document Type Size
1 IMMUCELL CORPORATION 8-K immucell8k.htm 8-K 19809
2 EXHIBIT 14 exh14.htm EX-14 37431
  Complete submission text file 0001102624-14-000412.txt   58324
Mailing Address 56 EVERGREEN DRIVE PORTLAND ME 04103
Business Address 56 EVERGREEN DR PORTLAND ME 04103 2078782770
IMMUCELL CORP /DE/ (Filer) CIK: 0000811641 (see all company filings)

EIN.: 010382980 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-12934 | Film No.: 14705550
SIC: 2835 In Vitro & In Vivo Diagnostic Substances